Relapsed/metastatic anal cancer
The names of the lead clinicians for the IRCI Relapsed/metastatic anal cancer group include:
Professor Dirk Arnold (EORTC)
Dr Al Benson (US)
Dr Rob Glynne-Jones (UK)
Current active trial
InterAAct – A Phase II International Multicentre Randomized Advanced Anal Cancer Trial Comparing Cisplatin plus 5FU vs. Carboplatin plus Weekly Paclitaxel in Patients with Relapsed or Metastatic Disease (International Rare Cancers Initiative study – IRCI 003)
